By shrinking the period between doses, we can see that the peaks and troughs, as we would expect, have reduced in amplitude
Examination: Exam +/- pH/microscopy/NAATs
Wondr is the and programwere not replacing diabetes management or sleep solutions, Wondr is a weight management solution that also helps improve the impact of your other programs
Ozempic (semaglutide 1 mg) : Originally approved for type 2 diabetes, Ozempic produces average weight loss of 8 to 14 pounds over 30 weeks at the 1 mg dose in the SUSTAIN trials
However, some side effects, such as those related to the gastrointestinal system, may persist longer for certain individuals
In a separate Phase 2 trial in people with type 2 diabetes, retatrutide produced an average 16.9% weight loss over 36 weeks along with improvements in blood sugar control